Still Sunday. Nothing's moving except the clock.
Market opens Monday, Oct 26 at 9:30 AM ET
ELAN · Large Cap · NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
Free AI brief
Free to track. No card required. Usually ready in 10-15 minutes.
Price, momentum, and the numbers behind the story.
Stocksbrew score
52/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Where the analysts and the crowd stand, and what it's worth to know first.
Current price
$22.51
Lowest
$26
Median target
$31.5
Highest
$34
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
Price / sales
Strong · Low price-to-sales
2.34x
Debt / equity
Favorable · 0.61 - strong leverage
0.64x
Current ratio
Strong · Good liquidity position
2.05x
ROIC
Weak · Weak capital efficiency
3.3%
ROE
Needs attention · Unfavorable
-3.0%
ELAN against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $11.77B | - | +11.9% | 52 | |
| $10.93B | 20.8 | +19.7% | 78 | |
| $29.41B | 30.8 | +15.5% | 78 | |
| $4.30B | 12.2 | +13.5% | 78 | |
| $1.20T | 43.3 | +49.6% | 77 |
Every story that touched the stock this week, newest first.